Skip to main content
Clinical Trials/PACTR201901535105039
PACTR201901535105039
Completed
未知

Prospective study comparing between the effects of fibrinogen concentrate, and recombinant activated factor VII on reduction of blood products transfusion requirements in elective coronary artery bypass surgery

Ain Shams University Hospitals0 sites80 target enrollmentDecember 20, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Ain Shams University Hospitals
Enrollment
80
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 20, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled coronary artery bypass grafting (CABG)
  • persistent clinical evidence of bleeding, after heparin reversal, requiring hemostatic therapy, as assessed by anesthetist.

Exclusion Criteria

  • Patients with previous cardiac surgery,
  • patients with previous history of coagulopathy or thromboembolic manifestations.
  • Patients with history of stroke.

Outcomes

Primary Outcomes

Not specified

Similar Trials